MEDI-SULTING TOPICAL PAIN RELIEF

Product NDC: 76074-123
11-digit product format: 760740123
Labeler code: 76074
Product ID: 76074-123_608c44c9-c680-4645-a80e-4445b10215d3
Type: HUMAN OTC DRUG
Nonproprietary name: METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE
Dosage form: PATCH
Route: TOPICAL
Labeler: Two Hip Consulting, LLC
Application: part348
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2012-08-18
Marketing end: 0000-00-00
Substance: METHYL SALICYLATE; MENTHOL; CAPSAICIN; LIDOCAINE
Active strength: 20 g/100g; g/100g; g/100g; g/100g
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	76074-123		I	Inactivated by FDA	2026-10-05
excluded product	product	76074-123		D	Discontinued by firm	2026-10-05
excluded package	package	76074-123	76074-123-21	I	Inactivated by FDA	2026-10-05
excluded package	package	76074-123	76074-123-21	D	Discontinued by firm	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 62 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	76074-123-21	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	76074-123-21	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	76074-123-21	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	76074-123-21	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	76074-123-21	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	76074-123-21	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	76074-123-21	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	76074-123-21	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	76074-123-21	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	76074-123-21	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	76074-123-21	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	76074-123-21	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	76074-123-21	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	76074-123-21	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	76074-123-21	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	76074-123-21	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	76074-123-21	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	76074-123-21	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	76074-123-21	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	76074-123-21	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	76074-123-21	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	76074-123-21	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	76074-123-21	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	76074-123-21	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	76074-123-21	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	76074-123-21	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	76074-123-21	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	76074-123-21	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	76074-123-21	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	76074-123-21	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
070fbed5-7088-434a-a7ce-f2a64d8d40ac	Product name	2	20260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80f	Product name	5	20250819
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57	Product name	3	20210602
473d070d-1c38-488e-b991-c4d1bf45aab8	Product name	1	20210201
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
aed701d5-9c75-dfaf-7154-cde46179faea	Product name	9	20200313
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508
49fa150c-f0de-cce7-3d9c-993ed81c5698	Product name	1	20140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ff	Product name	1	20140508
9137811f-f279-8640-5aeb-99fa2145d64d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
76074-123-21	2021-01-29	C162847	48780-1	ba0f9c33-4d93-a910-e053-dadaa90a0b85	627da02a-f843-455c-a31b-d190001bde39

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
76074-123-21	MEDI-SULTING TOPICAL PAIN RELIEF	10 g in 1 PATCH	PATCH	10		5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
76074-123-21	EA - Each	76074-123	0d8d27d4-3f21-4c58-96ce-e758602bb07c	1	2013-02-11

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CAPSAICIN	ACTIVE INGREDIENT	S07O44R1ZM	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
CAPSAICIN	ACTIVE INGREDIENT	S07O44R1ZM	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
LIDOCAINE	ACTIVE INGREDIENT	98PI200987	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
LIDOCAINE	ACTIVE INGREDIENT	98PI200987	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
MENTHOL	ACTIVE INGREDIENT	L7T10EIP3A	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
MENTHOL	ACTIVE INGREDIENT	L7T10EIP3A	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
METHYL SALICYLATE	ACTIVE INGREDIENT	LAV5U5022Y	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
METHYL SALICYLATE	ACTIVE INGREDIENT	LAV5U5022Y	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
CAPSAICIN	ACTIVE MOIETY	S07O44R1ZM	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
CAPSAICIN	ACTIVE MOIETY	S07O44R1ZM	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
LIDOCAINE	ACTIVE MOIETY	98PI200987	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
LIDOCAINE	ACTIVE MOIETY	98PI200987	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
MENTHOL	ACTIVE MOIETY	L7T10EIP3A	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
MENTHOL	ACTIVE MOIETY	L7T10EIP3A	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
ACRYLIC ACID	INACTIVE INGREDIENT	J94PBK7X8S	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
ACRYLIC ACID	INACTIVE INGREDIENT	J94PBK7X8S	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
ALUMINUM HYDROXIDE	INACTIVE INGREDIENT	5QB0T2IUN0	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
ALUMINUM HYDROXIDE	INACTIVE INGREDIENT	5QB0T2IUN0	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
ETHYLHEXYL ACETATE	INACTIVE INGREDIENT	2C7K8OA8SB	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
ETHYLHEXYL ACETATE	INACTIVE INGREDIENT	2C7K8OA8SB	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
ISOPROPYL MYRISTATE	INACTIVE INGREDIENT	0RE8K4LNJS	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
ISOPROPYL MYRISTATE	INACTIVE INGREDIENT	0RE8K4LNJS	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
METHYL ACRYLATE	INACTIVE INGREDIENT	WC487PR91H	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
METHYL ACRYLATE	INACTIVE INGREDIENT	WC487PR91H	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
NONOXYNOL-30	INACTIVE INGREDIENT	JJX07DG188	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
NONOXYNOL-30	INACTIVE INGREDIENT	JJX07DG188	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
POLYACRYLIC ACID (800000 MW)	INACTIVE INGREDIENT	D0I6NSZ87U	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
POLYACRYLIC ACID (800000 MW)	INACTIVE INGREDIENT	D0I6NSZ87U	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
SODIUM POLYACRYLATE (2500000 MW)	INACTIVE INGREDIENT	05I15JNI2J	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
SODIUM POLYACRYLATE (2500000 MW)	INACTIVE INGREDIENT	05I15JNI2J	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
SORBITAN SESQUIOLEATE	INACTIVE INGREDIENT	0W8RRI5W5A	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
SORBITAN SESQUIOLEATE	INACTIVE INGREDIENT	0W8RRI5W5A	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
TARTARIC ACID	INACTIVE INGREDIENT	W4888I119H	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
TARTARIC ACID	INACTIVE INGREDIENT	W4888I119H	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [PROFICIENT RX LP]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
76074-123	MEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) PATCH [TWO HIP CONSULTING, LLC]	5	Legacy NDC, 1 package rows	20190207_627da02a-f843-455c-a31b-d190001bde39.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
LAV5U5022Y	METHYL SALICYLATE	119-36-8	METHYL SALICYLATE
S07O44R1ZM	CAPSAICIN	404-86-4	CAPSAICIN
98PI200987	LIDOCAINE	137-58-6	LIDOCAINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1356803	capsaicin 0.035 % / lidocaine HCl 0.5 % / menthol 5 % / methyl salicylate 20 % Medicated Patch	PSN	627da02a-f843-455c-a31b-d190001bde39	5
1356803	capsaicin 0.00035 MG/MG / lidocaine hydrochloride 0.005 MG/MG / menthol 0.05 MG/MG / methyl salicylate 0.2 MG/MG Medicated Patch	SCD	627da02a-f843-455c-a31b-d190001bde39	5
1356803	capsaicin 0.035 % / lidocaine HCl 0.5 % / menthol 5 % / methyl salicylate 20 % Medicated Patch	SY	627da02a-f843-455c-a31b-d190001bde39	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
76074-123-21	76074012321	10 g in 1 PATCH	10 g	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
MEDI-SULTING TOPICAL PAIN RELIEF - Proficient Rx LP	Proficient Rx LP	2024-01-01	HUMAN OTC DRUG LABEL	3
MEDI-SULTING TOPICAL PAIN RELIEF - Two Hip Consulting, LLC	Two Hip Consulting, LLC	2019-02-06	HUMAN OTC DRUG LABEL	5